The Forecast Model builds upon the output of the Stock Valuation Model and combines this data with econometric and simulation techniques to output target prices for one, three, and six-month and one, two, and three-year time horizons.
Typically, these are motivated by a conspicuous success, a development program that was driven by the strength of beautiful molecular data, and the canonical example these days is PCSK9, a target which seems to feature an almost unprecedented alignment of human genetics, biomarker, and animal modeldata.